Cultured human foetal cerebral cortex, transfected with tyrosine hydroxylase cDNA, as a source of neural transplant material

Journal of Neural Transmission

Volumn 108, Issue 7, 2001, Pages 781-792

  Hurley, M J ^a   Gerard, D J ^a   Jauniaux, E ^b   Stern, G M ^c   Uchida, K ^d   Bradford, H F ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Departments of Obstetrics   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d KEIO UNIVERSITY   (Japan)

Author keywords

Human cell culture; Lipid mediated transfection; Neural transplantation; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

AMPHETAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL CULTURE; NERVE TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0034927496     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020170028     Document Type: Article

References (33)

1. Cerebral transplantation for Parkinson's disease: Current progress and future prospects
2. Better cells for brain repair
3. Fetal tissue transplantation for the treatment of Parkinson's disease: A review of the literature
4. Targets for gene therapy of Parkinson's disease: Growth factors, signal transduction, and promoters
5. Long-term behavioural recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase
6. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector
7. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders
8. Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: Regulated release of dopamine in mouse anterior pituitary AtT-20 cells
9. Exogenous expression of L-DOPA and dopamine in various cell lines following transfer of rat and human tyrosine hydroxylase cDNA: Grafting in an animal model of Parkinson's disease
10. Biochemical aspects of Parkinson's disease
11. Neural toxicity of retroviruses
12. Immune responses to adenoviral vectors during gene transfer in the brain
13. The principles of gene therapy for the nervous system
14. Cleavage of structural proteins during the assembly of the head of bacteriopghage T4
15. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: In vitro characterization and in vivo effects in the rat Parkinson model
16. Parkinson's disease
17. Gene therapy death prompts review of adenovirus vector
18. Introduction to model comparisons: One-way between-subjects designs
19. Neural transplantation in Parkinson's disease
20. Forskolin-induced expression of tyrosine hydroxylase in human foetal brain cortex
21. Neuronal-specific gene expression - The interaction of both positive and negative transcriptional regulators
22. Application of ex vivo gene therapy in the treatment of Parkinson's disease
23. Plasmid vectors
24. Tetrahydrobiopterin-dependent functional recovery in 6-hydroxydopamine-treated rats by intracerebral grafting of fibroblasts transfected with tyrosine hydroxylase cDNA
25. Quantitative recording of rotational behaviour in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system
26. The properties of cultured fetal human and rat brain tissue and its use as grafts for the relief of the parkinsonian syndrome
27. Grafting fibroblasts genetically modified to produce L-DOPA in a rat model of Parkinson disease
28. The stability of endogenous tyrosine hydroxylase protein in PC-12 cells differs from that expressed in mouse fibroblasts by gene transfer
29. Nerve growth factors and the control of neurotransmitter phenotype selection in the mammalian central nervous system
30. The influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplants
31. Induction of tyrosine hydroxylase gene expression in human foetal cerebral cortex
32. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery